I'm LongbridgeAI, I can summarize articles.Cabot CEO Sean Keohane sold 134,895 shares worth $11.5M on Aug 31, 2026. Analysts show mixed views: Truist raised its target citing strong battery-materials momentum, while UBS lowered it due to earnings declines in Reinforcement Materials and cash pressures. Cabot issued $350M notes to refinance debt. Spark AI rates CBT as Neutral, noting improved leverage but weak near-term cash flow.
New insider activity at Cabot ( (CBT) ) has taken place on August 31, 2026.
President and CEO Sean Keohane has recently executed a major stock sale involving 134,895 shares of Cabot stock, with the total transaction valued at $11,466,075. This sizeable move by the company’s top executive highlights a significant monetization of his Cabot holdings, drawing attention from investors tracking insider trading activity and leadership confidence signals.
Recent Updates on CBT stock
Cabot’s stock action over the last day reflects mixed analyst reactions to its latest earnings and financing moves, with Truist nudging up its target citing solid Q3 execution, strong Performance Chemicals and battery-materials momentum, and tighter FY26 EPS guidance that signals improved visibility. UBS, however, trimmed its target as it focused on the sharp earnings decline in Reinforcement Materials, expected margin normalization, and near‑term cash and working-capital pressures amid oil and raw-material volatility.
Recent news also centers on Cabot’s $350M 4.950% notes due 2029, used mainly to refinance 2026 notes and extend debt maturities, which improves liquidity but at a higher coupon and contributes to the balance-sheet narrative analysts are weighing. Spark’s AI assessments highlight the same push‑pull: improved leverage, profitability and constructive technicals against weaker recent earnings and free‑cash‑flow trends, reinforcing a view of steady but uneven progress driven by battery growth and offset by cyclical Reinforcement Materials headwinds.
Spark’s Take on CBT Stock
According to Spark, TipRanks’ AI Analyst, CBT is a Neutral.
CBT’s score is primarily supported by improved financial resilience (notably stronger leverage metrics) and constructive earnings-call fundamentals in Performance Chemicals/battery materials. The score is held back by weakening near-term earnings and free-cash-flow momentum, plus mixed technicals (below short-term moving averages with negative MACD) and a P/E that looks more “fair” than discounted.
To see Spark’s full report on CBT stock,
click here.
More about Cabot
YTD Price Performance: 28.38%
Average Trading Volume: 516,550
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.32B